2026 Annual Meeting | C155 - Therapy in Neurology 2

Date Tuesday 04/21/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kathryn S. Nevel, MD

Topic(s) General Neurology

Learning Objectives Attendees will learn and identify the current available therapeutic strategies for management of MS and demyelinating diseases, neuroinfectious disease, and cerebrovascular disease in this session. The course will consist of a review of current practices, the latest advancements in therapeutic options, and touch on emerging research in the treatment for each respective topic. The information covered in this course will be applicable to current clinical practice.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 04:05 PM CDT	Speaker	Therapy in MS and Demyelinating Diseases Jennifer McCombe, MD
04:05 PM - 04:40 PM CDT	Speaker	Therapy in Neuro-Infectious Disease Tracey Cho, MD, FAAN
04:40 PM - 05:15 PM CDT	Speaker	Therapy in Cerebrovascular Disease Rachel Beekman, MD
05:15 PM - 05:30 PM CDT	Q&A	Questions and Answers Tracey Cho, MD, FAAN, Jennifer McCombe, MD

Faculty Disclosures
Kathryn S. Nevel, MD	Dr. Nevel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Nevel has received publishing royalties from a publication relating to health care. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Interviewer with Continuum Audio.
Tracey Cho, MD, FAAN	Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Jennifer McCombe, MD	Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon therapeutics.
Rachel Beekman, MD	Dr. Beekman has nothing to disclose.

��ɫ��

��ɫ��